Clarity Medical Group Holding Limited (HKG:1406)
Hong Kong · Delayed Price · Currency is HKD 0.3550
+0.0200 (5.97%)
Apr 14, 2025, 9:50 AM HKT
HKG:1406 Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 177.82 | 180.59 | 190.93 | 213.85 | 225.24 | |
Revenue Growth | -1.54% | -5.42% | -10.71% | -5.06% | 1.28% |
Cost of Revenue | 89.94 | 90.81 | 101.3 | 93.09 | 83.03 |
Gross Profit | 87.88 | 89.78 | 89.64 | 120.76 | 142.21 |
Selling, General & Admin | 72.47 | 71.86 | 89.11 | 83.18 | 69.61 |
Other Operating Expenses | 42.46 | 28.44 | 19.37 | 20.39 | 15.02 |
Operating Expenses | 137.14 | 123.33 | 145.87 | 128.48 | 106.72 |
Operating Income | -49.26 | -33.55 | -56.23 | -7.72 | 35.49 |
Interest Expense | -0.79 | -1.04 | -2.02 | -1.53 | -0.78 |
Interest & Investment Income | 1.49 | 4.47 | 6.22 | 3.85 | 0.05 |
Currency Exchange Gain (Loss) | -0.04 | 0.01 | - | - | - |
Other Non Operating Income (Expenses) | 0.05 | 0.01 | 0.18 | 0.32 | -17.24 |
EBT Excluding Unusual Items | -48.54 | -30.1 | -51.85 | -5.07 | 17.51 |
Gain (Loss) on Sale of Assets | -0.01 | 0.26 | - | - | - |
Asset Writedown | -0.08 | -7.07 | -30.05 | -0.15 | - |
Other Unusual Items | 0.57 | - | - | 2.3 | 1.53 |
Pretax Income | -48.07 | -36.91 | -81.9 | -2.92 | 19.05 |
Income Tax Expense | -1.66 | -2.62 | -6.1 | 0.27 | 5.56 |
Net Income | -46.41 | -34.29 | -75.79 | -3.19 | 13.49 |
Net Income to Common | -46.41 | -34.29 | -75.79 | -3.19 | 13.49 |
Net Income Growth | - | - | - | - | -62.28% |
Shares Outstanding (Basic) | 536 | 529 | 528 | 522 | 390 |
Shares Outstanding (Diluted) | 536 | 529 | 528 | 522 | 391 |
Shares Change | 1.40% | 0.15% | 1.09% | 33.76% | 4.15% |
EPS (Basic) | -0.09 | -0.06 | -0.14 | -0.01 | 0.03 |
EPS (Diluted) | -0.09 | -0.06 | -0.14 | -0.01 | 0.03 |
EPS Growth | - | - | - | - | -63.61% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -29.05 | 10.34 | -48.39 | -13.98 | 27.35 |
Free Cash Flow Per Share | -0.05 | 0.02 | -0.09 | -0.03 | 0.07 |
Gross Margin | 49.42% | 49.72% | 46.95% | 56.47% | 63.14% |
Operating Margin | -27.70% | -18.57% | -29.45% | -3.61% | 15.75% |
Profit Margin | -26.10% | -18.99% | -39.70% | -1.49% | 5.99% |
Free Cash Flow Margin | -16.34% | 5.73% | -25.35% | -6.54% | 12.14% |
EBITDA | -39.42 | -22.91 | -40.34 | -1.54 | 43.19 |
EBITDA Margin | -22.17% | -12.68% | -21.13% | -0.72% | 19.18% |
D&A For EBITDA | 9.84 | 10.64 | 15.89 | 6.18 | 7.71 |
EBIT | -49.26 | -33.55 | -56.23 | -7.72 | 35.49 |
EBIT Margin | -27.70% | -18.57% | -29.45% | -3.61% | 15.75% |
Effective Tax Rate | - | - | - | - | 29.17% |